Certified by Founder
Lodge
Asimov
start up
United States
- Boston, Massachusetts
- 07/02/2023
- Series B
- $200,000,000
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
- Industry Biotechnology Research
- Website https://www.asimov.com/
- LinkedIn https://www.linkedin.com/company/asimov/about/
Voomi Supply | $10,000,000 | (Mar 10, 2026)
Axiomatic_AI | $18,000,000 | (Mar 10, 2026)
Advocacy | $3,500,000 | (Mar 10, 2026)
Crafting | $5,500,000 | (Mar 10, 2026)
Augur | $15,000,000 | (Mar 10, 2026)
ANEUVO | $22,000,000 | (Mar 10, 2026)
Mirai Robotics | $4,200,000 | (Mar 10, 2026)
KAST | $80,000,000 | (Mar 10, 2026)